Advertisement
Screener

EVOKE PHARMA, INC. Financing Cash Flow

EVOKE PHARMA, INC. Financing Cash Flow

EVOKE PHARMA, INC. reported Financing Cash Flow of $63.90 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-13

  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $38.90K, a 98.69% decline year-over-year.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $25.00K, a 99.67% decline year-over-year.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $3.50M.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2024 was $14.32M.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$119.30K, a 101.64% decline from fiscal 2022.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2022 was $7.29M, a 45.68% decline from fiscal 2021.
  • EVOKE PHARMA, INC. net cash provided by (used in) financing activities for fiscal 2021 was $13.43M, a 48.63% increase from fiscal 2020.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 80 monthNet Cash Provided by (Used in) Financing Activities 83 monthNet Cash Provided by (Used in) Financing Activities 86 month
2025-09-30$38.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$38.90K
derived: sum of 2 quarters · filed 2025-11-13
$63.90K
10-Q · filed 2025-11-13
$3.56M
derived: sum of 4 quarters · filed 2025-11-13
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$25.00K
10-Q · filed 2025-08-14
$3.52M
derived: sum of 3 quarters · filed 2025-08-14
$6.50M
derived: sum of 4 quarters · filed 2025-11-13
2025-03-31$25.00K
10-Q · filed 2025-05-13
$3.52M
derived: sum of 2 quarters · filed 2025-05-13
$6.50M
derived: sum of 3 quarters · filed 2025-11-13
$6.80M
derived: sum of 4 quarters · filed 2025-11-13
2024-12-31$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
$6.48M
derived: sum of 2 quarters · filed 2025-11-13
$6.77M
derived: sum of 3 quarters · filed 2025-11-13
$14.32M
10-K · filed 2025-03-13
2024-09-30$2.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$3.28M
derived: sum of 2 quarters · filed 2025-11-13
$10.82M
10-Q · filed 2025-11-13
2024-06-30$295.70K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$7.84M
10-Q · filed 2025-08-14
2024-03-31$7.54M
10-Q · filed 2025-05-13
2023-12-31-$119.30K
10-K · filed 2025-03-13
2022-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14
$0.00
derived: sum of 2 quarters · filed 2024-05-14
$7.12M
derived: sum of 3 quarters · filed 2024-05-14
$7.29M
10-K/A · filed 2024-05-14
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$7.12M
derived: sum of 2 quarters · filed 2023-11-09
$7.29M
10-Q · filed 2023-11-09
$7.29M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$7.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$7.29M
10-Q · filed 2023-08-10
$7.29M
derived: sum of 3 quarters · filed 2023-08-10
$7.61M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$171.52K
10-Q · filed 2023-05-15
$171.52K
derived: sum of 2 quarters · filed 2023-05-15
$484.63K
derived: sum of 3 quarters · filed 2023-05-15
$530.08K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21
$313.11K
derived: sum of 2 quarters · filed 2023-03-21
$358.56K
derived: sum of 3 quarters · filed 2023-03-21
$13.43M
10-K · filed 2023-03-21
2021-09-30$313.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$358.56K
derived: sum of 2 quarters · filed 2022-11-09
$13.43M
10-Q · filed 2022-11-09
$16.93M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$45.45K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$13.12M
10-Q · filed 2022-08-10
$16.62M
derived: sum of 3 quarters · filed 2022-08-10
$16.72M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$13.07M
10-Q · filed 2022-05-10
$16.57M
derived: sum of 2 quarters · filed 2022-05-10
$16.67M
derived: sum of 3 quarters · filed 2022-05-10
$22.08M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$3.60M
derived: sum of 2 quarters · filed 2022-03-08
$9.01M
derived: sum of 3 quarters · filed 2022-03-08
$9.04M
10-K · filed 2022-03-08
2020-09-30$100.79K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$5.51M
derived: sum of 2 quarters · filed 2021-11-10
$5.54M
10-Q · filed 2021-11-10
$5.84M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$5.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$5.43M
10-Q · filed 2021-08-12
$5.74M
derived: sum of 3 quarters · filed 2021-08-12
$5.87M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$21.25K
10-Q · filed 2021-05-12
$327.97K
derived: sum of 2 quarters · filed 2021-05-12
$451.78K
derived: sum of 3 quarters · filed 2021-05-12
$5.49M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$306.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$430.53K
derived: sum of 2 quarters · filed 2021-03-11
$5.47M
derived: sum of 3 quarters · filed 2021-03-11
$6.11M
10-K · filed 2021-03-11
2019-09-30$123.81K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
$5.16M
derived: sum of 2 quarters · filed 2020-11-10
$5.80M
10-Q · filed 2020-11-10
$5.80M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$5.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$5.68M
10-Q · filed 2020-08-06
$5.68M
derived: sum of 3 quarters · filed 2020-08-06
$6.86M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$636.43K
10-Q · filed 2020-05-12
$636.43K
derived: sum of 2 quarters · filed 2020-05-12
$1.82M
derived: sum of 3 quarters · filed 2020-05-12
$4.71M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$1.19M
derived: sum of 2 quarters · filed 2020-03-12
$4.07M
derived: sum of 3 quarters · filed 2020-03-12
$4.62M
10-K · filed 2020-03-12
2018-09-30$1.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$4.07M
derived: sum of 2 quarters · filed 2019-11-07
$4.62M
10-Q · filed 2019-11-07
$4.62M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$2.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$3.43M
10-Q · filed 2019-08-08
$3.43M
derived: sum of 3 quarters · filed 2019-08-08
$3.49M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$544.64K
10-Q · filed 2019-05-08
$544.64K
derived: sum of 2 quarters · filed 2019-05-08
$601.50K
derived: sum of 3 quarters · filed 2019-05-08
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
$56.86K
derived: sum of 2 quarters · filed 2019-03-06
$7.39M
10-K · filed 2019-03-06
2017-09-30$56.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$7.39M
10-Q · filed 2018-11-13
2017-06-30$7.33M
10-Q · filed 2018-08-09
2014-03-31-$360.58K
10-Q · filed 2014-05-13
$1.99M
derived: sum of 2 quarters · filed 2014-05-13
$45.86M
10-Q · filed 2014-05-13
2013-12-31$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
$27.12M
10-K · filed 2014-03-25
$46.22M
10-K · filed 2014-03-25
2013-09-30$24.77M
10-Q · filed 2013-11-13
$43.87M
10-Q · filed 2013-11-13
2013-03-31$2.00M
10-Q · filed 2014-05-13
$2.00M
derived: sum of 2 quarters · filed 2014-05-13
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
$1.00M
10-K · filed 2014-03-25
2012-09-30$1.00M
10-Q · filed 2013-11-13
2011-12-31-$277.78K
10-K · filed 2014-03-25